Experiment 987321

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationCREAGAN,ET: MOERTEL,CG: O'FALLON,JR: SCHUTT,AJ: O'CONNELL,MJ: RUBIN,J: FRYTAK,S:. (1979). FAILURE OF HIGH-DOSE VITAMIN C (ASCORBIC ACID) THERAPY TO BENEFIT PATIENTS WITH ADVANCED CANCER.. 301()
Amount utilized
Compound isolated
Disease150 PATIENTS WITH ADVANCED CANCER WERE USED IN A CONTROLLED DOUBLE-BLIND STUDY.DAILY DOSING. IMPROVEMENT IN PAIN CONTROL AND GENERAL STRENGTH IN VITAMIN C GROUP NO IMPROVEMENT IN APPETITE,ACTIVITY LEVEL,NAUSEA,VOMITING,HEARTBURN,DIARRHEA OR LEG SWELLING IN VITAMIN C GROUP
Dose amount10.0 GM
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES